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Transport proteinMitochondrial ADP/ATP carriers catalyze the equimolar exchange of ADP and ATP across themitochondrial inner
membrane. Structurally, they consist of three homologous domains with a single substrate binding site. They al-
ternate between a cytoplasmic andmatrix state inwhich the binding site is accessible to these compartments for
binding of ADP or ATP. It has been proposed that cycling between states occurs by disruption and formation of a
matrix and cytoplasmic salt bridge network in an alternatingway, but formation of the latter has not been shown
experimentally. Here, we show that state-dependent formation of the cytoplasmic salt bridge network can be
demonstrated by measuring the effect of mutations on the thermal stability of detergent-solubilized carriers
locked in a speciﬁc state. For this purpose, mutations were made to increase or decrease the overall interaction
energy of the cytoplasmic network. When locked in the cytoplasmic state by the inhibitor carboxyatractyloside,
the thermostabilities of the mutant and wild-type carriers were similar, but when locked in the matrix state by
the inhibitor bongkrekic acid, they correlated with the predicted interaction energy of the cytoplasmic network,
demonstrating its formation. Changing the interaction energy of the cytoplasmic network also had a profound ef-
fect on the kinetics of transport, indicating that formation of the network is a key step in the transport cycle. These
results are consistent with a unique alternating access mechanism that involves the simultaneous rotation of the
three domains around a central translocation pathway.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Members of the mitochondrial carrier family transport chemically
and structurally diverse compounds across the mitochondrial inner
membrane with a common, yet unresolved, mechanism [1–3]. The
mitochondrial ADP/ATP carrier (AAC), a member of the protein family,
imports ADP into the mitochondrion for conversion to ATP and exports
ATP synthesized by ATP synthase to the cytosol. The transport protein
cycles between a cytoplasmic and matrix state in which the substrate-
binding site is accessible to each of these compartments for binding of
ADP and ATP (Fig. 1A) [4]. The speciﬁc inhibitors atractyloside and
carboxyatractyloside (CATR) lock the transporter in an aborted
cytoplasmic state, whereas bongkrekic acid (BKA) locks the carrier in
an aborted matrix state [5–9]. These and other observations led to the
formulation of the 'single binding centre gated pore mechanism' foriophthora thermophila; CATR,
-(7-diethylamino-4-methyl-3-
.
. This is an open access article undermitochondrial carriers [4], which is essentially an alternating access
mechanism [10].
Mitochondrial carriers consist of three homologous sequence re-
peats, each coding for two transmembrane α-helices [11]. A low-
resolution projection structure of the yeast ADP/ATP carrier 3,
inhibited by atractyloside, showed that the carrier was a monomeric
three-fold pseudo-symmetrical α-helical bundle with a translocation
pore through the center [12]. The ﬁrst atomic structure of the bovine
mitochondrial ADP/ATP carrier, isolated from native sources and
inhibited by CATR, demonstrated that each of the three domains folds
into two transmembrane α-helices that are connected by a short α-
helix on the matrix side [13]. In the cytoplasmic state, the six trans-
membrane α-helices form a barrel around a central water-ﬁlled cavity,
which is accessible to the mitochondrial intermembrane space and, via
porins, to the cytosol [13]. By applying chemical and distance con-
straints [14,15] and by symmetry analysis [16] a single substrate-
binding site was identiﬁed in the central part of the cavity of the mito-
chondrial carriers. The same site was shown to bind ADP in the bovine
ADP/ATP carrier inmolecular dynamics simulations [17,18]. The contact
points of the substrate-binding site have been shown experimentally to
be determinants of substrate speciﬁcity/selectivity [14,15,19].the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 1. Transport states, architecture and cytoplasmic salt bridge network of themitochon-
drial ADP/ATP carrier fromMyceliophthora thermophila. (A) Reversible transport states of
the carrier, consisting of an empty cytoplasmic state, bound cytoplasmic state, bound oc-
cluded state, bound matrix state, and empty matrix state. Disruption and formation of
the cytoplasmic and matrix salt bridge networks, top and bottom respectively, have been
proposed to be involved in the opening and closing of the carrier to either side of themem-
brane in an alternatingway [16].Membrane view (B) and cytoplasmic view(C) of the com-
parative homology model (yellow) generated with SwissModel [40] based on the related
structure of Aac2p of Saccharomyces cerevisiae (PDB 4C9G) [21]. Acidic, basic and polar res-
idues of the matrix and cytoplasmic salt bridge network are shown as red, blue and green
sticks, respectively. The cysteine residues C65 andC229 are indicatedby orange sphere rep-
resentations. Schematic representations of the cytoplasmic salt bridge network of wild-
type (D) and networkmutants of AAC used in this study (E). The theoretical interaction en-
ergy is shown in the central gray circle, in which one point and half a point are assigned to
each salt bridge and hydrogen bond, respectively [16].
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matrix side of the carrier contain the signaturemotif of themitochondri-
al carrier family Px[DE]xx[RK] [20]. The proline residues of this motif arefound at sharp kinks of the L-shaped odd-numbered transmembraneα-
helices, as they break the hydrogen bond arrangement [13,21]. The
charged residues form an inter-domain salt bridge network in the cyto-
plasmic state, closing the carrier on thematrix side [13]. Underneath the
matrix network is a highly conserved glutamine residue that forms a
brace between residues of the salt bridge between domain 1 and 3, in-
creasing the interaction energy of the entire network [21]. The matrix
network and glutamine braces are part of the matrix gate together
with the C-terminal ends of the odd-numbered α-helices [13] and the
h12 matrix loop [13,21]. Another conserved motif [FY][DE]xx[RK] was
identiﬁed on each of the even-numbered transmembrane α-helices
[16]. These residues have been proposed to be part of the cytoplasmic
gate. When the gate is closed in the matrix state the conserved aromatic
residues may form a bulky hydrophobic layer [2,21], whereas the
charged residues of this motif might form a salt bridge network on the
cytoplasmic side of the carrier [16].Wehave previously shownby charge
reversal mutagenesis that these charged residues interact as part of the
transport cycle [21], but direct experimental evidence for the formation
of the cytoplasmic network in the matrix state is not available.
For this studywe have used themitochondrial ADP/ATP carrier from
Myceliophthora thermophile [22], a thermophilic fungus, which is stable
in detergent solutions in the unliganded form. A series of site-directed
mutations was created with the aim to increase or decrease the overall
interaction energy of the proposed cytoplasmic network systematically.
Mutant and wild-type AAC were puriﬁed, and a thermostability assay
was used to assess the effect of the mutations on protein stability
when the carriers were locked in either the cytoplasmic or the matrix
state with CATR or BKA, respectively. The results show that speciﬁc in-
teractions between residues of the cytoplasmic network form only
when the carrier is in the matrix state. The mutations of the network
also have amarked effect on the kinetics of transport, indicating that cy-
toplasmic network formation is a fundamental step in the transport
cycle of the mitochondrial ADP/ATP carrier.
2. Materials and methods
2.1. Protein puriﬁcation and thermostability assays
2.1.1. Construction of yeast wild-type and mutant AAC expression strains
The codon-optimized gene of the mitochondrial ADP/ATP carrier
fromMyceliophthora thermophila was synthesized with an N-terminal
eight histidine tag and Factor Xa cleavage site (Genscript) and cloned
into the yeast expression vector pYES-PMIR2-AAC2 [23]. Site-directed
mutations were introduced in the gene by using overlap-extension
PCR [24] with KOD HotStart polymerase (Novagen). For the introduc-
tion of multiple mutations, several rounds of site-directed mutagenesis
were performed. Expression vectors were transformed by electropora-
tion into Saccharomyces cerevisiae strain WB12 (MATα ade2-1 trp1-1
ura3-1 can1-100 aac1::LEU2 aac2::HIS3) [25], which lacks functional
Aac1p and Aac2p carriers. Transformants were selected initially on SC
medium minus tryptophan plates, and then on YPG plates, conﬁrming
they expressed functional ADP/ATP carriers.
2.1.2. Preparation of lipid for protein puriﬁcation
Tetraoleoyl cardiolipin (18:1) dissolved in chloroform was pur-
chased from Avanti Polar Lipids (Alabaster, Alabama). Typically,
100 mg of lipid was dispensed into a glass vial, and chloroform was
removed by evaporation under a stream of nitrogen. Lipids were sol-
ubilized in 10% (w/v) dodecyl-maltoside by vortexing for 4 h at room
temperature to give 10 mg ml−1 lipid in a 10% detergent stock. The
stocks were snap-frozen and stored in liquid nitrogen.
2.1.3. Puriﬁcation of wild-type and mutant AAC
For each wild-type and mutant AAC, a ﬁve-liter pre-culture was
used to inoculate 100 l of YPG medium in an Applikon 140 Pilot Sys-
tem with an eZ controller. Cells were grown at 30 °C for 72 h, and
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were prepared with established methods [12], ﬂash frozen in liquid
nitrogen, and stored at−80 °C until use. Isolated yeast mitochondria
(250 mg total protein) were solubilized in 3% dodecyl-β-maltoside
(Glycon Biochemicals GmbH) dissolved in a buffer consisting of
20 mM imidazole, 150 mM NaCl, 20 mM HEPES/NaOH, pH 8.0, and
an EDTA-free complete protease inhibitor tablet (Roche Diagnostics
Ltd.) by mixing at 4 °C for one hour. Particulate material was re-
moved by ultracentrifugation (140,000 g, 45 min, 4 °C). The soluble
fraction was loaded onto a Ni-Sepharose high performance column
(Amersham Biosciences) at 1 ml min−1 on an ÄKTAprime (GE
Healthcare). The column was washed with 40 column volumes of
buffer containing 20 mM HEPES/NaOH pH 8.0, 150 mM NaCl,
20 mM imidazole, 0.1% dodecyl-maltoside and 0.10 mg ml−1
tetraoleoyl cardiolipin (18:1). The column material was washed
with a further 20 column volumes of buffer B containing 20 mM
HEPES/NaOH pH 8.0, 50 mM NaCl, 0.1% dodecyl-maltoside and
0.10 mg ml−1 tetraoleoyl cardiolipin (18:1). For each preparation,
the column material was resuspended with 400 μL buffer B, and
transferred to a vial containing 5 mM CaCl2 and 75 μg Factor Xa
(New England BioLabs), vortexed thoroughly, and incubated at 10 °C
overnight. The following day, the cleaved protein was separated from
the nickel sepharose media using ﬁltration and centrifugation, the
protein concentration was determined and adjusted to 3 mg ml−1
with buffer B, and the sample was snap-frozen and stored in liquid
nitrogen.
2.1.4. Thermostability assays
Thermostability data were obtained by using the thiol-reactive
ﬂuorophore N-[4-(7-diethylamino-4-methyl-3-coumarinyl)phenyl]
maleimide (CPM), which undergoes an increase in ﬂuorescence emis-
sion following reaction with cysteine residues [26]. A rapid procedure
using a rotary qPCR machine was used, as described previously [22].
For this purpose, a 5 mg ml−1 stock of CPM dissolved in DMSO was di-
luted 50-fold into buffer containing 20 mM HEPES/NaOH pH 8.0,
150 mM NaCl, 0.1% dodecyl-maltoside and 0.10 mg ml −1 tetraoleoyl
cardiolipin (18:1), vortexed and the solutionwas allowed to equilibrate
in the dark at room temperature for 10 min. Three micrograms of pro-
teinwas added into a ﬁnal volume of 45 μL buffer B, and 5 μL CPMwork-
ing solution was added, and the solution was vortexed and allowed to
equilibrate in the dark for 10 min at room temperature in the presence
of 50 μMADP/20 μMCATR or 50 μMADP/20 μMBKA for the compounds
to take effect, or on ice for 10 min without inhibitor to keep the protein
stable. Fluorescence of the CPM dye was measured on a Qiagen
Rotorgene Q using the HRM channel, which provides excitation light
at 440–480 nmwith emission detected at 505–515 nm. Measurements
weremade in 1 °C intervals from 25 to 90 °Cwith a ‘wait between read-
ing’ set to 4 s, which equated to a ramp rate of 5.6 °C/min, following an
initial pre-incubation step of 90 s. Data were analyzed andmelting tem-
peratures (the inﬂection point of the melting curve) were determined
with the software supplied with the instrument. Four micrograms of
protein were used in each assay. In total 27 experiments were carried
out; three independent puriﬁcations, three separate Rotor-Gene-Q
runs, each in triplicate.
2.2. Protein expression in Lactococcus lactis
2.2.1. Construction of lactococcal wild-type and mutant AAC expression
strains
For optimal expression in Lactococcus lactis [27], residues 2–14
and 309–315 were removed by PCR, including the His-tag, and the
resulting genes were cloned into the expression vector pNZ8048
under the control of a nisin A-inducible promoter [28]. The plasmids
were transformed in L. lactis strain NZ9000 by electroporation, as
previously described [27,29,30]. Vectors were isolated by miniprep
(Qiagen), according to the manufacturer's instructions with onealteration: 10 mg ml-1 lysozyme was added to the lysis buffer and
the resuspended cells were incubated at 55 °C for twenty minutes
prior to lysis. Gene insertions were conﬁrmed by sequencing.
2.2.2. Growth of Lactococcus lactis and membrane isolation
Pre-cultures of L. lactis were obtained by inoculating M17 medi-
um supplemented with 1% (w/v) glucose and 5 μg ml−1 chloram-
phenicol from glycerol stocks and incubating the cultures overnight
at 30 °C with no aeration. The cells were diluted to a starting A600
of 0.1 in fresh M17 medium supplemented with 1% (w/v) glucose
and 5 μg ml−1 chloramphenicol. Cells were grown at 30 °C with no
aeration until the A600 reached 0.5; the expression of the recombi-
nant proteins was induced by addition of nisin A with a dilution of
1:10,000 of spent M17 medium from nisin A-excreting L. lactis strain
NZ9700. The cells were grown for a further 2 h at 30 °C, harvested by
centrifugation (6000 g, 10 min, 4 °C), resuspended in PBS buffer and
collected by centrifugation as before. The cells were subsequently re-
suspended in 50 ml PBS buffer and disrupted mechanically with a
cell disruptor (Constant Cell Disruption Systems) at 30 kpsi. Whole
cells and debris were removed by centrifugation (10,800 g, 15 min,
4 °C), and the membranes were collected by ultracentrifugation
(138,000 g, 1 h, 4 °C). Pellets were resuspended in PBS buffer to a
total protein concentration of approximately 5 mg ml−1 and stored
in liquid nitrogen.
2.2.3. Preparation of lipid for membrane vesicle fusions
For liposome preparation, E. coli polar lipid extract and egg yolk
phosphatidylcholine (20 mg ml−1 in chloroform) were mixed in a
mass ratio of 3:1. The chloroformwas evaporated under a stream of ni-
trogen, the lipidswere resuspended in PBS bufferwith a homogenizer to
a ﬁnal concentration of 20 mg ml−1 and frozen in liquid nitrogen.
2.2.4. Membrane vesicle fusions and transport assays
To make membrane fusions, 1 mg of lactococcal membranes were
mixed with 5 mg liposomes, diluted to a ﬁnal volume of 900 μl with
PBS, and fusedby seven cycles of freezing in liquid nitrogen and thawing
at room temperature before storage in liquid nitrogen. The membrane
vesicle fusions were thawed, and 100 μl 10× substrate added. Vesicles
were extruded 11 times through a 1-μm polycarbonate ﬁlter, passed
through a pre-equilibrated PD10 column to remove external substrate,
and collected in 1.6 ml PBS buffer. Transport assays were carried out
by using a Hamilton MicroLab Star robot (Hamilton Robotics Ltd.,
Birmingham). Transport of 14C-labeled ADP was initiated by the addi-
tion of 100 μL PBS buffer with 1.5 μM 14C-ADP (2.22 GBq mmol−1) to
5 μg fused membranes in a MultiScreenHTS-HA 96-well ﬁlter plate
(pore size =0.45 μm; Millipore). The transport was started to give 0 s,
10 s, 20 s, 30 s, 45 s, 60 s, 150 s, 5 min, 7.5min, 10min and 15min incu-
bation times with 14C-ADP, and stopped by the addition of 200 μl ice-
cold PBS buffer and ﬁltering using a vacuum manifold, followed by an
additional wash step with 200 μl ice-cold PBS buffer. Levels of radioac-
tivity in the vesicles were measured by the addition of 200 μl
MicroScint-20 (Perkin Elmer) and by quantifying the amount of radio-
activity with a TopCount scintillation counter (Perkin Elmer). Initial
rates were determined from the linear part of the uptake curves in the
ﬁrst 60 s; background binding of 14C-ADP to lactococcal membranes
was determined with an uninduced control strain, and subtracted
from the rate. The speciﬁc 14C-ADP uptake rates (permg AAC)were cal-
culated following the quantiﬁcation of wild type and mutant AAC by
Western blot analysis, using a standard curve of puriﬁed MtAAC.
3. Results
The putative cytoplasmic salt bridge network of mitochondrial ADP/
ATP carrier (AAC) fromMyceliophthora thermophila [22] consists of res-
idues D101 and K104, D205 and K208, and D299 and Q302 on trans-
membrane α-helices H2, H4 and H6, respectively. They are located at
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and do not interact when the carrier is in the cytoplasmic state [21]
(Fig. 1B and C). It has been proposed that in the matrix state the cyto-
plasmic network engages by forming bonds between residues D101-
K208, D205-Q302, and D299-K104 (Fig. 1D) [16]. Previously, we have
introduced a qualitativemeasure for the interaction energy of these net-
works by counting the number of potential salt bridge and hydrogen
bond interactions, assuming that hydrogen bonds have about half the
interaction energy of a salt bridge [16]. On this basis the cytoplasmic
network of wild-type AAC has a putative interaction energy of 2.5,
based on two salt bridges and one hydrogen bond (Fig. 1D).We have in-
troduced a series of mutations into the carrier with the aim to increase
or decrease the overall interaction energy of the putative cytoplasmic
network. The Q302K mutation results in a three-fold symmetrical salt
bridge network with an interaction energy of 3.0 (Fig. 1E). The Q302A
mutation eliminates the hydrogen bond interaction, generating a net-
work with an interaction energy of 2.0 (Fig. 1E). In this way the interac-
tion energy of the cytoplasmic network was varied from 3.0 to 0.5
(Fig. 1E).
Since polar interactions are relatively large contributors to the over-
all stability of proteins, we reasoned that these mutations should affect
the stability of the carrier in a state-dependent manner. To obtain a
measure for protein stability, we employed a thermostability assay
that uses the probe N-[4-(7-diethylamino-4-methyl-3-coumarinyl)-
phenyl]-maleimide (CPM), which reacts with exposed protein thiols
to form a ﬂuorescent adduct [26]. In the procedure, the temperature of
puriﬁed protein samples is increased from 25 to 90 °C while proteinFig. 2. Thermostability proﬁles of puriﬁedwild-typeAAC in the presence of inhibitors and substr
BKA-inhibited AAC (C) in the presence (red line) or absence (blue line) of ADP (left panels). (D
peratures are indicated.unfolding is monitored with CPM, as buried cysteine residues become
solvent exposed due to thermal denaturation [22]. The apparent
melting temperature is derived from the peak in the derivative of the
melting curve, which corresponds to the temperature at which approx-
imately half of a given protein population is unfolded (melted). For the
assay, AAC was puriﬁed in dodecyl-maltoside in the presence of
tetraoleoyl-cardiolipin, which is required to stabilize the unliganded
carrier. This AAC has only two cysteines: C65 in matrix α-helix h12
and C229 in transmembrane α-helix H5 (Fig. 1B and C).
The unfolding proﬁles of the wild-type AAC were determined in the
absence or presence of carboxyatractyloside (CATR) or bongkrekic acid
(BKA) (Fig. 2). As the binding of these inhibitors is state-dependent, it
was necessary to also add the substrate ADP to allow cycling between
states. Importantly, ADP binds with low afﬁnity, which is insufﬁcient
to interferewith binding or release of these high afﬁnity inhibitors. Con-
sequently, even in the presence of ADP, the carrier is locked in either the
aborted matrix or cytoplasmic state. In the absence of inhibitor, the
carrier had a low apparent melting temperature of ~50 °C, whether
ADP was present or not (Fig. 2A and D). Addition of CATR resulted in a
~33 °C increase in the apparent melting temperature of wild-type
AAC, whereas the addition of ADP had little effect on protein stability,
indicating that the carrier was indeed locked in an aborted state
(Fig. 2B and E).
BKA locks the protein in thematrix state [31], where the cytoplasmic
network is predicted to form. The unfolding proﬁle of wild-type AAC
incubated with BKA alone had two apparent melting temperatures,
indicating that the population was divided in two differentates. Representative unfolding proﬁles of uninhibitedAAC (A), CATR-inhibitedAAC (B) and
–F) Derivatives of the unfolding proﬁles of A–C, respectively. The apparent melting tem-
Fig. 3. Residue C65 becomes accessible when the ADP/ATP carrier is in the matrix state. Representative unfolding proﬁles of puriﬁed wild-type AAC (A) or mutant C65A (B) without ad-
ditions (black line) or inhibitedwith CATR (blue line) or BKA (red line) in the presence of ADP. (C andD)Derivatives of the unfolding proﬁles (A and B), respectively. The apparentmelting
temperatures are indicated.
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parentmelting temperature of 52 °C, similar to unliganded AAC (50 °C).
The smaller population had an apparent melting temperature of 61 °C,
indicating that the carrier is in the BKA-inhibited state, which leads to
an increase in thermostability by 11 °C. The combination of ADP and
BKA had two effects. First, the population was homogeneous with an
apparent melting temperature of 61 °C. This result conﬁrmed that the
substrate ADP is able to shift all of the carriers to the matrix state for
binding of BKA, as observed previously [4]. Second, a higher baseline
of ﬂuorescence prior to temperature ramping was observed, which
corresponded to about half the total ﬂuorescence signal. This result in-
dicated that one of the two cysteines was already exposed when all of
the carriers were locked in the matrix state. To investigate this effect
further, wemutated C65 in matrixα-helix h12 of wild-type AAC to ala-
nine (C65A) (Fig. 1B and C). Themutant C65Awas subjected to thermo-
stability assays in the presence of ADP with either CATR or BKA. The
initial ﬂuorescence levels of the uninhibited and CATR-inhibited C65A
mutant were low, similar to thewild-type protein (Fig. 3A and B). How-
ever, in the presence of BKA the raised baseline ﬂuorescence apparent
inwild-type AACwas absent in the C65Amutant. The total ﬂuorescence
of the unfolded C65A mutant after denaturation was about half that of
the unfolded wild-type AAC. Taken together, these results show that
C65 becomes available when the carrier is locked in the matrix state
by BKA, whereas C229 only becomes available as a result of thermal de-
naturation. Therefore, the raised baseline ﬂuorescence associated with
labeled C65 is a marker of the carrier being in the BKA-inhibited matrix
state. These results also show that the unliganded AAC is in the cyto-
plasmic state (no raised baseline) and that ADP is required for the entire
population of carriers to convert from the cytoplasmic to the matrix
state for BKA binding.
The apparent melting temperatures for wild-type and mutant C65A
were very similar in the absence of inhibitor (50.0 and 47.5 °C, respec-
tively) or the presence of CATR plus ADP (83.5 and 82.0 °C, respectively)
(Fig. 3C and D), demonstrating that both states are not affected by the
mutation. There was a slightly bigger difference between the two in
the presence of BKA plus ADP (61 and 67 °C, respectively), indicatingthat adduct formation at C65 prior to the thermal ramp may lead to
mild destabilization of thewild-type protein in thematrix state. In sum-
mary, the unliganded AAC in detergent is able to bind the state-speciﬁc
inhibitors CATR and BKA and to cycle between states through substrate-
induced conformational changes, indicating that it has retained the
known properties of the protein in the membrane. All subsequent ex-
periments were carried out in the presence of ADP to obtain a homoge-
neous population of carrier in an aborted cytoplasmic or matrix state.
3.1. Interaction energy of the cytoplasmic network determines the stability
of the matrix state
To test the effect of the cytoplasmic network mutations on protein
stability, we determined the apparent melting temperatures for the
wild-type and all mutant AAC (Fig. 1D and E) in the absence or presence
of CATR + ADP or BKA + ADP (Fig. 4 and Fig. S1). In the absence of in-
hibitor, the melting temperatures of the wild type and mutants were
very similar (50–55 °C). When inhibited with CATR+ ADP, themelting
temperatures of all of the mutants increased by ~30 °C (83–85 °C).
These results show that the mutant proteins are well folded, as they
are still capable of binding CATR in the cytoplasmic state.
When the wild-type and mutant carriers were incubated with
BKA+ ADP, there was a strong correlation between the apparent melt-
ing temperatures and the putative interaction energies of the cytoplas-
mic network. Relative to wild-type AAC, the melting temperature of
Q302K was 5 °C higher, indicating that the mutant was more stable in
thematrix state, consistentwith a higher interaction energy. The appar-
entmelting temperature of Q302Awith a putative interaction energy of
2.0 was 58.6 °C, almost two degrees lower than wild type. The melting
temperatures of K104A and K208A with interaction energies of 1.5
were 4.7 and 6.5 °C lower than Q302A, respectively. The mutant
K104A + Q302A with a cytoplasmic network interaction energy of 1.0
had a melting temperature of 51.8 °C, the lowest that could be deter-
mined. The mutant with the weakest network, K104A + K208A, could
not be locked in the matrix state by BKA + ADP, as was evident from
the absence of a raised baseline ﬂuorescence (Fig. S1).
Fig. 4.Average apparentmelting temperatures of puriﬁedwild-type andmutant AAC. Ap-
parentmelting temperature of AAC was determined in the absence of inhibitor (black) or
in the presence of CATR plus ADP (blue) or BKA plus ADP (red). The mutant
K104A + K208A could not be locked in the BKA-inhibited matrix state (see text for de-
tails), and thus themelting temperature could not be determined. The theoretical interac-
tion energy is shown between brackets (see legend to Fig. 1). The data are represented by
the average and standard deviation of 27 experiments using three separate protein puriﬁ-
cations, three separate Rotor-Gene-Q runs, each in triplicate. Representative unfolding
proﬁles are shown in Fig. S1.
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We investigated the effect of the mutations of the cytoplasmic net-
work on the transport rate in fused membrane vesicles of Lactococcus
lactis [29] by monitoring the speciﬁc initial rate of exchange of internal
unlabeled ADP for external labeled 14C-ADP (Fig. 5 and Fig. S2). Controls
using membrane-impermeable CATR showed that all of the carriers
were oriented with the cytoplasmic side to the outside. The transport
experiments showed that all mutants transported ADP, albeit with dif-
ferent rates, indicating that they were well folded consistent with the
effect of the CATR on protein stability (Fig. 4). The speciﬁc initial trans-
port rate was the highest for the wild-type AAC (10.7 ADP μmol mg−1
min−1, network 2.5). The mutants Q302K (6.2 μmol mg−1 min−1, net-
work 3.0) and Q302A (9.1 μmolmg−1 min−1, network 2.0) transported
ADP at slightly lower rates. However, mutants with cytoplasmic net-
work interaction energies of 1.5 or lower had much lower transport
rates (Fig. 5A). K104A + K208A (network 0.5) had a transport rate of
0.9 μmol mg−1 min−1, about twelve times less than that of wild-type
AAC.
We also determined the effect of the cytoplasmic networkmutations
on the apparent Km and Vmax of transport (Fig. S3). The Km values
were in the range of 8.7–12.4 μM for the wild type and most of the
mutants (Table 1), indicating that the mutations did not affectsubstrate binding signiﬁcantly. The only exception was Q302K,
which had a lower apparent Km of 2.2 μM. The Vmax values were high
for the wild-type and Q302A mutant, being 65.7 and 73.0 μmol ADP
mg−1 min-1, respectively. The Vmax value of Q302K (network 3.0) was
approximately one third of the wild-type AAC, whereas the other Vmax
values decreased with decreasing interaction energy of the cytoplasmic
network (Table 1). These results show that interactions of the cytoplas-
mic network are important determinants of the transport rate of AAC.
The effect of the inhibitors on the transport rate was also determined.
The results show that addition of CATR led to a full inhibition of trans-
port by the wild-type and mutant AAC (Fig. 5B and S2). In contrast,
the inhibition by BKA was dependent on the interaction energy of the
cytoplasmic network. Mutant Q302K and wild-type AAC were almost
completely inhibited by BKA (N98%), whereas mutant Q302A was
inhibited to 91%, K104A to 81%, K208A to 69%, K104A + Q302A to
28%, and K104A + K208A to 19%.
4. Discussion
We have previously proposed a domain-based alternating access
mechanism for mitochondrial carriers [16,21]. Key to this mecha-
nism is the formation of the cytoplasmic salt bridge network when
the carrier is in the matrix state, which is demonstrated experimen-
tally in this work. A series of mutant carriers were engineered in
which the interaction energy of the cytoplasmic network increased
or decreased compared to the wild-type. All of these mutants were
capable of transporting ADP (Fig. 5A), albeit with different rates,
and were fully inhibited by CATR (Fig. 5B). In the CATR-inhibited
state, which is a locked cytoplasmic state, the apparent melting tem-
perature was very similar for all of the network mutants, approxi-
mately 83 °C, conﬁrming that they all were able to bind CATR
(Fig. 4). The marked increase in thermostability due to CATR binding
is consistent with the structures of bovine AAC1 [13] and yeast Aac2p
and Aac3p [21], which show that CATR is bound to the central cavity
by an extensive network of salt bridges, hydrogen bonds and hydro-
phobic contacts, cross-linking most of the transmembraneα-helices.
The observations that thermostability increases by the same amount
for all mutants also shows that the residues of the cytoplasmic net-
work are not interacting in the aborted cytoplasmic state in agree-
ment with the structures [13,21]. The initial ﬂuorescence of the
unfolding curves for the uninhibited carriers was very low, demon-
strating that all carriers were well folded and in the cytoplasmic
state at the start of the thermal stability assays (Fig. S1). Strikingly,
when the carriers were locked in the matrix state by BKA by the ad-
dition of ADP, a strong correlation between the predicted interaction
energies of the cytoplasmic network and the apparent melting tem-
peratures was observed (Fig. 4). Notably, the thermal stability of the
Q302K mutant was higher than that of the wild-type in agreement
with a replacement of a hydrogen bond with a salt bridge. All other
mutations led to a decreased stability in the BKA-inhibited state, cor-
relating strongly with the expected interaction energy. With the ex-
ception of K104A + K208A, all of the mutants and the wild type
could be locked in the matrix state by BKA, as they exhibited an in-
creased baseline of ﬂuorescence, indicative of C65 being accessible
to the probe. It has been observed previously that sulfhydryl re-
agents react with cysteine residues in the matrix α-helices, which
leads to inhibition of the transport activity [32]. Taken together, the
results demonstrate that residues of the cytoplasmic network are
key determinants of protein stability only when the carriers are
locked in the matrix state, which is consistent with formation of
the cytoplasmic network. The strict correlation also indicates that
the network forms symmetrically, as all of interactions of the net-
work were shown to be important even though their positions dif-
fered. In further agreement, the mutants K104A and K208A (both
with an interaction energy of 1.5) had similar thermostabilities and
transport properties, even though different bonds in the network
Fig. 5. Speciﬁc initial transport rates and percentage inhibition of thewild-type andmutant AAC. The speciﬁc initial transport rateswere determinedwith fusedmembranes of Lactococcus
lactis expressing the wild-type or mutant carriers (A), loaded with ADP. The theoretical interaction energy is shown between brackets (see legend to Fig. 1). Percentage of inhibition of
transport (B) in the presence of CATR (blue line) or BKA (red line). The speciﬁc ADP uptake rates (per mg of AAC) were corrected for background binding. The error bars represent the
standard deviation of four assays. Student t-tests: P N 0.05, not signiﬁcant (NS); P N 0.01, *; P N 0.001, **; P N 0.0001, ***; P b 0.0001, ****.
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demonstrate that individual bonds between amino acid residues can
be detected in a state-dependent manner, which is a useful tool for
the characterization of detergent-solubilized membrane proteins.
Another important observation is that the cytoplasmic network is a
key determinant of the inhibitory effect of BKA (Fig. 5B), providing fur-
ther support for the notion that formation of the matrix state and bind-
ing of BKA are interlinked, as noted previously [4]. BKA is a relatively
long and ﬂexible molecule with only three carboxylic groups, providing
fewer and weaker binding opportunities than CATR (Fig. S4). In agree-
ment, the shift in apparent melting temperature is much smaller (11
°C for BKA versus 33 °C for CATR for the wild-type). Thus the formation
of the cytoplasmic network is required for BKA to exert its inhibitory ef-
fect. These results demonstrate also that the thermostability assays are
useful for characterizing ligand-protein interactions, as shown previ-
ously for GDP and cardiolipin binding to the uncoupling protein [33].
The effects of the mutations on the transport cycle can be explained
with a schematic energy diagram of the transport states (Fig. 6). TheTable 1
Kinetic parameters determined for wild-type and mutant MtAAC.
Mutant Apparent Km (μM)⁎ Vmax (μmol 14C-ADP mg AAC−1 min−1)⁎
Q302K 2.2 ± 0.3 21.9 ± 0.9
Wildtype 9.3 ± 1.8 65.7 ± 7.1
Q302A 11.2 ± 2.3 73.0 ± 9.0
K104A 12.4 ± 3.7 19.0 ± 3.5
K208A 9.4 ± 2.0 14.8 ± 1.8
K104A + Q302A 11.9 ± 4.0 11.6 ± 2.3
K104A + K208A 8.7 ± 1.7 3.9 ± 0.5
⁎ Values represent the average and standard error of four measurements.Induced Transition Fit theory of transport catalysis, formulated by
Klingenberg, has introduced the important concept that the energy bar-
rier for conversion between states is lowered by substrate binding [34,
35]. At the time, however, the energy barriers of the transport process
were not structurally deﬁned for mitochondrial carriers. We now
know that carriers operate as monomers [23,32,36] with a single sub-
strate binding site in the central cavity ﬂanked by two salt bridge net-
works [13,14,16], which are the largest contributors to inter-domain
interactions [21].
The transition state in the absence of substrate is a dynamic short-
livedhigh-energy state inwhich the residues of the salt bridge networks
are not or only weakly interacting (Fig. 6, top). The formation of salt
bridge networks in the substrate-free matrix or cytoplasmic state
lowers the energy levels considerably (Fig. 6). Therefore, there is a
very low probability for the networks to disrupt spontaneously and
for the carrier to reach the high energy levels of the transition state
due to thermal energy. Consequently, the carrier is trapped in the low
energy levels of the matrix or cytosolic state in agreement with the ex-
perimental observations that the inter-conversion between states in the
absence of substrate is extremely slow [4]. The salt bridge interactions of
the matrix network are highly conserved [15,37] and braced by gluta-
mine residues to increase the overall interaction energy of the network
to 3.5 in the qualitative measure introduced earlier [16,21].
Binding of substrate lowers the free energy depending on the
strength of the bonds formed, which in turn depends on the precise ge-
ometry of the substrate in its binding site (lower black lines, Fig. 6). The
free energy of the transition state is thus lowered sufﬁciently for the
substrate-bound carrier to cycle between thematrix and cytosolic states
in both directions by thermal energy [34,35]. The same principles are
likely to apply to themechanismof other transport proteins, but the dif-
ferences in energy levels may be larger in the case of mitochondrial
Fig. 6. Schematic energy diagrams of thewild-type andmutant fungal ADP/ATP carriers with different interaction energies of the cytoplasmic network. The energy states of the wild-type
carrier are shown in black, whereas those of the mutant carriers are shown in rainbow colors, varying from an putative interaction energy of the cytoplasmic salt bridge network of 3.0
(purple) to 0.5 (red), as indicated in the legend. Arrows indicate the reversible steps between transport states of the wild type. The bold arrow indicates the change in free energy
upon substrate binding in the transition state. Pictorial representations of the transport states are also shown. The transition state is an occluded state with the residues of the networks
not or only weakly interacting. The mitochondrial matrix (m) and the intermembrane space, which is continuous with the cytoplasm (c) are also indicated.
21M.S. King et al. / Biochimica et Biophysica Acta 1857 (2016) 14–22ADP/ATP carriers, because of the salt bridge interactions of the net-
works. Consequently, a substantial amount of interaction energy must
be involved in substrate binding too in order to lower the energy barrier
sufﬁciently for transport to occur. The substrate binding site of the bo-
vine mitochondrial ADP/ATP carrier has been proposed to consist of
G182, I183 and Y186 for binding of the adenine moiety and R79, K22
and R279 for binding of the phosphate groups [14–18], which could
form an aromatic stacking and three ionic interactionswith ADP, consis-
tent with this idea.
By introducing mutations it was possible to increase or decrease
the interaction energy of the cytoplasmic network in a systematic
way (colored levels, Fig. 6). Therefore, the free energy of the matrix
state is altered, whereas the free energy of the cytoplasmic state is
unaffected (Fig. 6). On the basis of sequence information the cyto-
plasmic network of the fungal ADP/ATP carriers has an interaction
energy of 2.5, whereas mammalian ones have an interaction energy
of 3.0. Since all of the wild-type and mutant carriers lack a raised
baseline ﬂuorescence in the absence of ADP and BKA (Fig. S1), they
are most likely in the cytoplasmic state, indicating that the
substrate-free cytoplasmic state has a lower energy level than the
substrate-free matrix state, as depicted in Fig. 6.
The effect of the mutations on the kinetic parameters of transport
were also determined (Table 1). There was a marked effect on theVmax of transport caused by mutations of the cytoplasmic network.
The Vmax values were high when the interaction energies of the cyto-
plasmic network were in the range of 3.0–2.0, but very low in the
range of 1.5–0.5. The energy diagram can explain why there is a sharp
decline in the transport rate, as the probability of forming matrix states
will be very low in the lattermutants, affecting the overall transport rate
(Fig. 6). The energy levels of the substrate-free matrix state of the mu-
tant with weak networks could be close to the energy level of the
substrate-free or empty transition state. Thus they could convert spon-
taneously to the cytoplasmic state in the absence of substrate, but they
would be trapped there, because the conversion back to thematrix state
represents a large change in free energy. In agreement themutant with
the weakest cytoplasmic network was trapped in the cytoplasmic state
(see lack of raised ﬂuorescent baseline in the presence of BKA and ADP,
Fig. S1).
The apparent Km of transport for wild-type AAC was 9.3 μM, which
is compatible with values for the ADP/ATP carrier of Saccharomyces
cerevisiae [38]. The Km values of most mutants were not signiﬁcantly
different from that of the wild type, consistent with the location of res-
idues in the cytoplasmic network away from central substrate binding
site, where they are unlikely to have a direct involvement in substrate
binding [14,15]. In the case of the Q302K mutant, the Km value was
much lower, 2.2 μM. Thismutation lowers the energy level of thematrix
22 M.S. King et al. / Biochimica et Biophysica Acta 1857 (2016) 14–22state involved in substrate binding (Fig. 6) and thus the probability of
being in that state would be much higher. Consequently, the Km
would be lower, as it represents the apparent dissociation constant for
the sum of all bound states, including the substrate bound matrix
state [39]. With these data we are building a statistical mechanics
model to test these and other properties of the mitochondrial ADP/
ATP carrier.
In conclusion, the experimental data in this paper support a unique
transport mechanism that provides an alternating access of the sub-
strate to the binding site by the simultaneous rotation of the three do-
mains around a central translocation pathway through the disruption
and formation of two salt bridge networks.
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